New hope drug enters human testing for tough cancers
Disease control
Recruiting now
This is the first study testing the experimental drug JR8603 in people. It aims to find a safe dose and see if it helps control advanced solid tumors, particularly stomach, esophageal junction, and colorectal cancers, when standard treatments have stopped working. The study will …
Phase: PHASE1 • Sponsor: JiaRay Group • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC